Clinical Trial Update: LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether Levetiracetam can prevent seizures in adults with Down syndrome who have symptomatic Alzheimer's disease; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome
• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Down Syndrome, Down Syndrome (DS) | Phase 3 | Status: RECRUITING